Otsuka Holdings Co Ltd
TSE:4578

Watchlist Manager
Otsuka Holdings Co Ltd Logo
Otsuka Holdings Co Ltd
TSE:4578
Watchlist
Price: 8 594 JPY -0.07% Market Closed
Market Cap: 4.6T JPY
Have any thoughts about
Otsuka Holdings Co Ltd?
Write Note
Otsuka Holdings Co Ltd
/
Cash Flow Statement
/
Cash from Operating Activities

Otsuka Holdings Co Ltd
Cash from Operating Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Otsuka Holdings Co Ltd
Cash from Operating Activities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash from Operating Activities CAGR 3Y CAGR 5Y CAGR 10Y
Otsuka Holdings Co Ltd
TSE:4578
Cash from Operating Activities
¥379.8B
CAGR 3-Years
16%
CAGR 5-Years
11%
CAGR 10-Years
8%
Takeda Pharmaceutical Co Ltd
TSE:4502
Cash from Operating Activities
¥876.3B
CAGR 3-Years
-5%
CAGR 5-Years
10%
CAGR 10-Years
14%
Daiichi Sankyo Co Ltd
TSE:4568
Cash from Operating Activities
¥583.9B
CAGR 3-Years
73%
CAGR 5-Years
25%
CAGR 10-Years
17%
S
Shionogi & Co Ltd
TSE:4507
Cash from Operating Activities
¥187.5B
CAGR 3-Years
17%
CAGR 5-Years
3%
CAGR 10-Years
12%
Chugai Pharmaceutical Co Ltd
TSE:4519
Cash from Operating Activities
¥409.9B
CAGR 3-Years
17%
CAGR 5-Years
21%
CAGR 10-Years
27%
Astellas Pharma Inc
TSE:4503
Cash from Operating Activities
¥200.8B
CAGR 3-Years
-15%
CAGR 5-Years
-4%
CAGR 10-Years
-1%
No Stocks Found

Otsuka Holdings Co Ltd
Glance View

Market Cap
4.6T JPY
Industry
Pharmaceuticals

Otsuka Holdings Co. Ltd. began its journey in 1921 as a small chemicals company in Naruto, Japan. Its evolution from those humble beginnings to a global pharmaceutical giant is marked by its relentless commitment to innovation and expansion. Today, Otsuka operates as a holding company, orchestrating a diversified portfolio across pharmaceuticals, nutraceuticals, consumer products, and medical devices. It has cultivated a unique philosophy: a balance between large-scale operations and niche markets. The company’s pharmaceutical sector, its most significant revenue contributor, is driven largely by advancements in CNS (central nervous system) treatments and nephrology. The success of its flagship product, Abilify, a leading antipsychotic, underscores Otsuka’s ability to combine market demands with cutting-edge research to sustain growth and profitability. In parallel, Otsuka nurtures its nutraceuticals wing, embodied by its signature Pocari Sweat and SoyJoy brands. These products epitomize the company’s strategy of creating and expanding niche markets, offering health-oriented products that resonate with evolving consumer health trends. This diversification into consumer products and nutraceuticals not only complements its pharmaceutical endeavors but also mitigates risks by tapping into varied revenue streams. By focusing on health and wellness broadly, Otsuka Holdings strategically positions itself to navigate the complexities of the global healthcare market, ensuring a resilient business model. Through this multifaceted approach, Otsuka sustains its growth, reaffirming its legacy as a dynamic and globally influential company.

Intrinsic Value
9 450.44 JPY
Undervaluation 9%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Otsuka Holdings Co Ltd's Cash from Operating Activities?
Cash from Operating Activities
379.8B JPY

Based on the financial report for Sep 30, 2024, Otsuka Holdings Co Ltd's Cash from Operating Activities amounts to 379.8B JPY.

What is Otsuka Holdings Co Ltd's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
8%

Over the last year, the Cash from Operating Activities growth was 67%. The average annual Cash from Operating Activities growth rates for Otsuka Holdings Co Ltd have been 16% over the past three years , 11% over the past five years , and 8% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,800+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.